These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7028802)

  • 1. The dopamine system challenge in affective disorders: a review of behavioral and neuroendocrine responses.
    Insel TR; Siever LJ
    J Clin Psychopharmacol; 1981 Jul; 1(4):207-13. PubMed ID: 7028802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apomorphine induced alteration in corneofundal potentials in depression.
    Demet EM; Albers L; Sokolski KN; Chicz-Demet A; Chen CC; Reist C
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 Jul; 21(5):775-88. PubMed ID: 9278949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of carbamazepine on dopamine- and serotonin-mediated neuroendocrine responses.
    Elphick M; Yang JD; Cowen PJ
    Arch Gen Psychiatry; 1990 Feb; 47(2):135-40. PubMed ID: 2105705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin and growth hormone response to levodopa in affective illness.
    Linkowski P; Brauman H; Mendlewicz J
    Neuropsychobiology; 1983; 9(2-3):108-12. PubMed ID: 6621850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Relation to duration of illness and depressive symptoms.
    Meltzer HY; Kolakowska T; Fang VS; Fogg L; Robertson A; Lewine R; Strahilevitz M; Busch D
    Arch Gen Psychiatry; 1984 May; 41(5):512-9. PubMed ID: 6721674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine responses to apomorphine in depressed patients and healthy control subjects.
    Jimerson DC; Cutler NR; Post RM; Rey A; Gold PW; Brown GM; Bunney WE
    Psychiatry Res; 1984 Sep; 13(1):1-12. PubMed ID: 6595680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide challenges in affective illness.
    Cohen RM; Cohen MR
    J Clin Psychopharmacol; 1981 Jul; 1(4):214-22. PubMed ID: 6117586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine and behavioral responses to psychological stress in hyperandrogenic women.
    Modell E; Goldstein D; Reyes FI
    Fertil Steril; 1990 Mar; 53(3):454-9. PubMed ID: 2137794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopathological correlates of dopaminergic disturbances in major depression.
    Pitchot W; Hansenne M; Moreno AG; von Frenckell R; Ansseau M
    Neuropsychobiology; 1990-1991; 24(4):169-72. PubMed ID: 2135707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic function in panic disorder: comparison with major and minor depression.
    Pitchot W; Ansseau M; Gonzalez Moreno A; Hansenne M; von Frenckell R
    Biol Psychiatry; 1992 Dec; 32(11):1004-11. PubMed ID: 1467380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin and growth hormone responses in the amenorrhea-galactorrhea syndrome.
    Hagen TC; Sill AJ; Garthwaite TL; Halverson G; Borkowf HI
    Obstet Gynecol; 1980 Aug; 56(2):204-7. PubMed ID: 7190256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine strategies in affective disorders.
    Grof E; Brown GM; Grof P
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):557-62. PubMed ID: 6420843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine factors in affective disorders.
    Ansseau M; Pitchot W; Papart P; Gonzalez Moreno A; Lembreghts M; Legros JJ
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():574A-575A. PubMed ID: 1498956
    [No Abstract]   [Full Text] [Related]  

  • 14. Some neuroendocrine parameters in bipolar and unipolar depression.
    Mendlewicz J; Linkowski P; Van Cauter E
    J Affect Disord; 1979 Mar; 1(1):25-32. PubMed ID: 162179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine evaluation of catecholaminergic neurotransmission in mania.
    Ansseau M; von Frenckell R; Cerfontaine JL; Papart P; Franck G; Timsit-Berthier M; Geenen V; Legros JJ
    Psychiatry Res; 1987 Nov; 22(3):193-206. PubMed ID: 2829258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine effects of carbamazepine in patients with affective illness.
    Joffe RT; Post RM; Ballenger JC; Rebar R; Gold PW
    Epilepsia; 1986; 27(2):156-60. PubMed ID: 3082622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A view on noradrenergic, hypothalamic-pituitary-adrenal axis and extrahypothalamic corticotrophin-releasing factor function in anxiety and affective disorders: the reduced growth hormone response to clonidine.
    Coplan JD; Pine DS; Papp LA; Gorman JM
    Psychopharmacol Bull; 1997; 33(2):193-204. PubMed ID: 9230631
    [No Abstract]   [Full Text] [Related]  

  • 18. Stress and affective disorders: animal models elucidating the molecular basis of neuroendocrine-behavior interactions.
    Touma C
    Pharmacopsychiatry; 2011 May; 44 Suppl 1():S15-26. PubMed ID: 21544741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seasonal and mood independence of low basal prolactin secretion in premenopausal women with seasonal affective disorder.
    Depue RA; Arbisi P; Spoont MR; Krauss S; Leon A; Ainsworth B
    Am J Psychiatry; 1989 Aug; 146(8):989-95. PubMed ID: 2640544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine effects of limbic activation by electrical, spontaneous, and pharmacological modes: relevance to the pathophysiology of affective dysregulation in psychiatric disorders.
    Kling MA; Kellner CH; Post RM; Cowdry RW; Gardner DL; Coppola R; Putnam FW; Gold PW
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(4):459-81. PubMed ID: 2827235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.